Larry Noracle Partners Lp O... Net Worth

The estimated Net Worth of Larry Noracle Partners Lp O... is at least $39.3 Миллион dollars as of 17 February 2017. Larry O owns over 617,731 units of Vermillion stock worth over $39,301,156 and over the last 10 years Larry sold VRML stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Larry O VRML stock SEC Form 4 insiders trading

Larry has made over 4 trades of the Vermillion stock since 2014, according to the Form 4 filled with the SEC. Most recently Larry bought 617,731 units of VRML stock worth $864,823 on 17 February 2017.

The largest trade Larry's ever made was buying 972,222 units of Vermillion stock on 23 December 2014 worth over $1,400,000. On average, Larry trades about 435,673 units every 131 days since 2014. As of 17 February 2017 Larry still owns at least 9,825,289 units of Vermillion stock.

You can see the complete history of Larry O stock trades at the bottom of the page.

Insiders trading at Vermillion

Over the last 17 years, insiders at Vermillion have traded over $1,008,376 worth of Vermillion stock and bought 29,557,130 units worth $34,088,488 . The most active insiders traders include Jack W Schuler, Henri George Schuler и Larry Noracle Partners Lp F.... On average, Vermillion executives and independent directors trade stock every 59 days with the average trade being worth of $1,572,028. The most recent stock trade was executed by Robert Harry Beechey on 15 November 2019, trading 5,000 units of VRML stock currently worth $3,550.

What does Vermillion do?

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Complete history of Larry O stock trades at Vermillion

Vermillion executives and stock owners

Vermillion executives and other stock owners filed with the SEC include:

• Valerie Palmieri,
  President, Chief Executive Officer, Director
• Robert Beechey,
  Chief Financial Officer
• Nancy Cocozza,
  Independent Director
• James LaFrance,
  Independent Chairman of the Board
• Veronica Jordan,
  Independent Director
• David Schreiber,
  Independent Director
• James Burns,
  Independent Director
• Sandra Brooks,
  Independent Director
• Jack W Schuler,
  
• Peter S Roddy,
  Director
• Carl Severinghaus,
  Director
• Larry Noracle Partners Lp O...,
  
• Donald G Munroe,
  SVP Business Development & CSO
• Henri George Schuler,
  10% owner
• Holly B Bauzon,
  VP Managed Markets
• Fred Ferrara,
  Chief Information Officer
• Rajen Dalal,
  Director
• Gail S Page,
  President and CEO
• Qun Zhou,
  Interim CFO
• Laura Ann Miller,
  SVP Sales & Cust Experience
• Robert St Leger Goggin,
  Director
• Ashish Kohli,
  VP of Corporate Strategy
• Michael J Callaghan,
  Director
• Marian E Sacco,
  See Remarks
• Thomas H Mclain,
  CEO & President
• James L Rathmann,
  Director
• Eric Varma,
  Director
• Larry Noracle Partners Lp O...,
  
• John F Hamilton,
  Director
• William C Wallen,
  Director
• Bruce A Huebner,
  Director
• William B. Creech,
  VP Sales and Marketing
• Eric Schoen,
  VP Finance & CAO
• Eric T Fung,
  VP-Chief Science Officer
• Sandra A. Gardiner,
  VP & Chief Financial Officer
• Judy Bruner,
  Director
• Partners L Pwiggins James P...,
  
• Diagnostics Inc Quest,
  10% owner
• Kenneth J Conway,
  Director
• Simon C. Shorter,
  VP, Corp Business Development
• John A Young,
  Director
• Larry Noracle Partners Lp F...,